Chalcone derivative, preparation method and application in medicine
Through the structural modification and compound design of Pseudomonas aeruginosa C, highly effective anti-tumor chalcone derivatives have been developed, which solves the problem of limited inhibitory effect of existing anti-tumor drugs on various tumor cells and achieves the goal of inhibiting multiple tumor cells. Significant inhibition of tumor cells and effective attack of drug-resistant cells.
Patent Information
- Application Number
- CN201410206107.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2014-05-15
- Publication Date
- 2015-11-25
- Estimated Expiration
- 2034-05-15
AI Technical Summary
Existing anti-tumor drugs have limited inhibitory effects on a variety of tumor cells and suffer from drug resistance problems, making it difficult to effectively target multiple types of cancer cells.
A series of chalcone derivatives were developed by structurally modifying Pseudomonas trichophylla C. These compounds were prepared using the Claisen-Schmidt condensation method and purified by reaction under alkaline conditions and high performance liquid chromatography to form compounds with New compounds with high antitumor activity.
These derivatives show significant anti-tumor activity and have potent inhibitory effects on a variety of tumor cells, including drug-resistant nasopharyngeal carcinoma cells. They also significantly increase the inhibition rate by inducing apoptosis mechanisms, providing new anti-tumor treatments. plan.
